Pfizer Gets 2nd Request For Info On $68B Wyeth Deal
This “second request” for information was anticipated as part of the regulatory process, according to Pfizer.
“Pfizer intends to respond expeditiously to this request and continue to work cooperatively with the FTC in connection with its review,” the pharmaceutical giant said in a statement.
Before the transaction becomes final, it is still subject to the expiration of...
To view the full article, register now.